CORESTEMCHEMON Statistics

Total Valuation

CORESTEMCHEMON has a market cap or net worth of KRW 123.51 billion. The enterprise value is 162.10 billion.

Market Cap	123.51B
Enterprise Value	162.10B

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

CORESTEMCHEMON has 24.36 million shares outstanding. The number of shares has increased by 5.76% in one year.

Current Share Class	n/a
Shares Outstanding	24.36M
Shares Change (YoY)	+5.76%
Shares Change (QoQ)	+23.86%
Owned by Insiders (%)	16.22%
Owned by Institutions (%)	0.08%
Float	20.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.76
PB Ratio	5.12
P/TBV Ratio	6.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.27
EV / Sales	5.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.00

Financial Position

The company has a current ratio of 0.35, with a Debt / Equity ratio of 1.70.

Current Ratio	0.35
Quick Ratio	0.14
Debt / Equity	1.70
Debt / EBITDA	n/a
Debt / FCF	-1.01
Interest Coverage	-4.89

Financial Efficiency

Return on equity (ROE) is -148.58% and return on invested capital (ROIC) is -24.64%.

Return on Equity (ROE)	-148.58%
Return on Assets (ROA)	-15.75%
Return on Capital (ROIC)	-24.64%
Revenue Per Employee	81.36M
Profits Per Employee	-106.89M
Employee Count	355
Asset Turnover	0.31
Inventory Turnover	55.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.83% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.83%
50-Day Moving Average	12,736.60
200-Day Moving Average	11,741.05
Relative Strength Index (RSI)	27.59
Average Volume (20 Days)	711,560

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CORESTEMCHEMON had revenue of KRW 28.88 billion and -37.94 billion in losses. Loss per share was -1,832.72.

Revenue	28.88B
Gross Profit	-2.86B
Operating Income	-23.80B
Pretax Income	-37.88B
Net Income	-37.94B
EBITDA	-18.77B
EBIT	-23.80B
Loss Per Share	-1,832.72

Full Income Statement

Balance Sheet

The company has 2.50 billion in cash and 41.09 billion in debt, giving a net cash position of -38.59 billion or -1,584.33 per share.

Cash & Cash Equivalents	2.50B
Total Debt	41.09B
Net Cash	-38.59B
Net Cash Per Share	-1,584.33
Equity (Book Value)	24.14B
Book Value Per Share	990.94
Working Capital	-33.95B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.98 billion and capital expenditures -23.51 billion, giving a free cash flow of -40.49 billion.

Operating Cash Flow	-16.98B
Capital Expenditures	-23.51B
Free Cash Flow	-40.49B
FCF Per Share	-1,662.15

Full Cash Flow Statement

Margins

Gross margin is -9.90%, with operating and profit margins of -82.39% and -131.37%.

Gross Margin	-9.90%
Operating Margin	-82.39%
Pretax Margin	-131.15%
Profit Margin	-131.37%
EBITDA Margin	-64.98%
EBIT Margin	-82.39%
FCF Margin	n/a

Dividends & Yields

CORESTEMCHEMON does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.76%
Shareholder Yield	-5.76%
Earnings Yield	-36.15%
FCF Yield	-32.78%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CORESTEMCHEMON has an Altman Z-Score of -0.63. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.63
Piotroski F-Score	n/a